These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27960558)

  • 1. Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases.
    Serafino A; Sferrazza G; Colini Baldeschi A; Nicotera G; Andreola F; Pittaluga E; Pierimarchi P
    Expert Opin Drug Discov; 2017 Feb; 12(2):169-186. PubMed ID: 27960558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges.
    Serafino A; Giovannini D; Rossi S; Cozzolino M
    Expert Opin Drug Discov; 2020 Jul; 15(7):803-822. PubMed ID: 32281421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Zhang Y; Wang X
    J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling as potential therapeutic target in lung cancer.
    Yang J; Chen J; He J; Li J; Shi J; Cho WC; Liu X
    Expert Opin Ther Targets; 2016 Aug; 20(8):999-1015. PubMed ID: 26882052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New avenues to target Wnt/β-catenin signaling.
    Verkaar F; Zaman GJ
    Drug Discov Today; 2011 Jan; 16(1-2):35-41. PubMed ID: 21111060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for Chemical Suppressors of the Wnt/β-catenin Signaling Pathway].
    Nishiya N
    Yakugaku Zasshi; 2017; 137(2):133-136. PubMed ID: 28154320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature-derived compounds modulating Wnt/
    Sferrazza G; Corti M; Brusotti G; Pierimarchi P; Temporini C; Serafino A; Calleri E
    Acta Pharm Sin B; 2020 Oct; 10(10):1814-1834. PubMed ID: 33163337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Wnt/β-catenin signaling pathway in human cancers.
    Yao H; Ashihara E; Maekawa T
    Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent updates on Wnt signaling modulators: a patent review (2014-2020).
    Goswami VG; Patel BD
    Expert Opin Ther Pat; 2021 Nov; 31(11):1009-1043. PubMed ID: 34128760
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
    Laranjeira AB; Yang SX
    Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
    Vilchez V; Turcios L; Marti F; Gedaly R
    World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors.
    Ferri M; Liscio P; Carotti A; Asciutti S; Sardella R; Macchiarulo A; Camaioni E
    Eur J Med Chem; 2017 Dec; 142():506-522. PubMed ID: 29107427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy.
    Liu D; Chen L; Zhao H; Vaziri ND; Ma SC; Zhao YY
    Biomed Pharmacother; 2019 Sep; 117():108990. PubMed ID: 31226638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Wnt pathway: emerging anticancer strategies.
    Gupta A; Verma A; Mishra AK; Wadhwa G; Sharma SK; Jain CK
    Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):138-47. PubMed ID: 23432158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt signaling pathway: implications for therapy in lung cancer and bone metastasis.
    Xi Y; Chen Y
    Cancer Lett; 2014 Oct; 353(1):8-16. PubMed ID: 25042867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics.
    Harb J; Lin PJ; Hao J
    Curr Oncol Rep; 2019 Feb; 21(2):12. PubMed ID: 30715618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease.
    Zhou T; Zu G; Zhang X; Wang X; Li S; Gong X; Liang Z; Zhao J
    Neuropharmacology; 2016 Feb; 101():480-9. PubMed ID: 26525190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of targeting Wnt/β-catenin in colon cancer.
    Sebio A; Kahn M; Lenz HJ
    Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the WNT Signaling Pathway in Cancer Therapeutics.
    Tai D; Wells K; Arcaroli J; Vanderbilt C; Aisner DL; Messersmith WA; Lieu CH
    Oncologist; 2015 Oct; 20(10):1189-98. PubMed ID: 26306903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.